181 related articles for article (PubMed ID: 21807014)
1. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated disruption of the CD40 ligand-induced activation of primary human B cells.
Lu H; Crawford RB; Kaplan BL; Kaminski NE
Toxicol Appl Pharmacol; 2011 Sep; 255(3):251-60. PubMed ID: 21807014
[TBL] [Abstract][Full Text] [Related]
2. 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated suppression of toll-like receptor stimulated B-lymphocyte activation and initiation of plasmacytic differentiation.
North CM; Crawford RB; Lu H; Kaminski NE
Toxicol Sci; 2010 Jul; 116(1):99-112. PubMed ID: 20348231
[TBL] [Abstract][Full Text] [Related]
3. Suppression of human B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin involves altered regulation of B cell lymphoma-6.
Phadnis-Moghe AS; Crawford RB; Kaminski NE
Toxicol Sci; 2015 Mar; 144(1):39-50. PubMed ID: 25543051
[TBL] [Abstract][Full Text] [Related]
4. Induction of the aryl hydrocarbon receptor-responsive genes and modulation of the immunoglobulin M response by 2,3,7,8-tetrachlorodibenzo-p-dioxin in primary human B cells.
Lu H; Crawford RB; Suarez-Martinez JE; Kaplan BL; Kaminski NE
Toxicol Sci; 2010 Nov; 118(1):86-97. PubMed ID: 20702590
[TBL] [Abstract][Full Text] [Related]
5. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) elevates basal B-cell intracellular calcium concentration and suppresses surface Ig- but not CD40-induced antibody secretion.
Karras JG; Morris DL; Matulka RA; Kramer CM; Holsapple MP
Toxicol Appl Pharmacol; 1996 Apr; 137(2):275-84. PubMed ID: 8661353
[TBL] [Abstract][Full Text] [Related]
6. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the regulation and posttranslational modification of p27kip1 in lipopolysaccharide-activated B cells.
Crawford RB; Sulentic CE; Yoo BS; Kaminski NE
Toxicol Sci; 2003 Oct; 75(2):333-42. PubMed ID: 12883080
[TBL] [Abstract][Full Text] [Related]
7. Aryl hydrocarbon receptor activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin impairs human B lymphopoiesis.
Li J; Phadnis-Moghe AS; Crawford RB; Kaminski NE
Toxicology; 2017 Mar; 378():17-24. PubMed ID: 28049042
[TBL] [Abstract][Full Text] [Related]
8. All-or-none suppression of B cell terminal differentiation by environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Zhang Q; Kline DE; Bhattacharya S; Crawford RB; Conolly RB; Thomas RS; Andersen ME; Kaminski NE
Toxicol Appl Pharmacol; 2013 Apr; 268(1):17-26. PubMed ID: 23357550
[TBL] [Abstract][Full Text] [Related]
9. Involvement of Blimp-1 and AP-1 dysregulation in the 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated suppression of the IgM response by B cells.
Schneider D; Manzan MA; Yoo BS; Crawford RB; Kaminski N
Toxicol Sci; 2009 Apr; 108(2):377-88. PubMed ID: 19237549
[TBL] [Abstract][Full Text] [Related]
10. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated impairment of B cell differentiation involves dysregulation of paired box 5 (Pax5) isoform, Pax5a.
Schneider D; Manzan MA; Crawford RB; Chen W; Kaminski NE
J Pharmacol Exp Ther; 2008 Aug; 326(2):463-74. PubMed ID: 18483191
[TBL] [Abstract][Full Text] [Related]
11. Characterization of protein phosphorylation by 2,3,7,8-tetrachlorodibenzo-p-dioxin in murine lymphocytes: indirect evidence for a role in the suppression of humoral immunity.
Snyder NK; Kramer CM; Dooley RK; Holsapple MP
Drug Chem Toxicol; 1993; 16(2):135-63. PubMed ID: 8486096
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of TCDD-induced AhR-mediated gene expression in human, mouse and rat primary B cells.
Kovalova N; Nault R; Crawford R; Zacharewski TR; Kaminski NE
Toxicol Appl Pharmacol; 2017 Feb; 316():95-106. PubMed ID: 27913140
[TBL] [Abstract][Full Text] [Related]
13. The Influence of Human Interindividual Variability on the Low-Dose Region of Dose-Response Curve Induced by 2,3,7,8-Tetrachlorodibenzo-p-Dioxin in Primary B Cells.
Dornbos P; Crawford RB; Kaminski NE; Hession SL; LaPres JJ
Toxicol Sci; 2016 Oct; 153(2):352-60. PubMed ID: 27473338
[TBL] [Abstract][Full Text] [Related]
14. Selective effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and corticosteroid on in vitro lymphocyte maturation.
Luster MI; Germolec DR; Clark G; Wiegand G; Rosenthal GJ
J Immunol; 1988 Feb; 140(3):928-35. PubMed ID: 3257509
[TBL] [Abstract][Full Text] [Related]
15. TCDD-mediated suppression of naïve human B cell IgM secretion involves aryl hydrocarbon receptor-mediated reduction in STAT3 serine 727 phosphorylation and is restored by interferon-γ.
Blevins LK; Zhou J; Crawford R; Kaminski NE
Cell Signal; 2020 Jan; 65():109447. PubMed ID: 31678681
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of calcium-dependent B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Karras JG; Holsapple MP
Toxicol Appl Pharmacol; 1994 Apr; 125(2):264-70. PubMed ID: 8171434
[TBL] [Abstract][Full Text] [Related]
17. Anti-CD40 Treatment of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-exposed C57Bl/6 mice induces activation of antigen presenting cells yet fails to overcome TCDD-induced suppression of allograft immunity.
Shepherd DM; Steppan LB; Hedstrom OR; Kerkvliet NI
Toxicol Appl Pharmacol; 2001 Jan; 170(1):10-22. PubMed ID: 11141351
[TBL] [Abstract][Full Text] [Related]
18. Aryl hydrocarbon receptor-dependent inhibition of AP-1 activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin in activated B cells.
Suh J; Jeon YJ; Kim HM; Kang JS; Kaminski NE; Yang KH
Toxicol Appl Pharmacol; 2002 Jun; 181(2):116-23. PubMed ID: 12051995
[TBL] [Abstract][Full Text] [Related]
19. The long winding road toward understanding the molecular mechanisms for B-cell suppression by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Sulentic CE; Kaminski NE
Toxicol Sci; 2011 Mar; 120 Suppl 1(Suppl 1):S171-91. PubMed ID: 20952503
[TBL] [Abstract][Full Text] [Related]
20. Suppression of the IgM Response by Aryl Hydrocarbon Receptor Activation in Human Primary B Cells Involves Impairment of Immunoglobulin Secretory Processes.
Zhou J; Henriquez J; Crawford R; Kaminski N
Toxicol Sci; 2018 May; 163(1):319-329. PubMed ID: 29462421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
